Clinical Trial Update: Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation [Phase 1, Phase 2]

View source ↗

Summary

This document reports completion of a Phase 1/2 clinical trial evaluating Autologous Bone Repair Cell (BRC) Therapy for sinus floor bone augmentation in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tooth Loss

Drugs mentioned

• Autologous Bone Repair Cell (BRC) Therapy

Snippet

Sponsor: University of Michigan | Conditions: Tooth Loss | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-12-23